Advantis Corporation (ADVT: OTC Pink Limited) | Advantis CEO, Christopher Swartz, Addresses Recent Unauthorized Promotion of Advantis Stock by Stellar Media Group and Others.


Advantis CEO, Christopher Swartz, Addresses Recent Unauthorized Promotion of Advantis Stock by Stellar Media Group and Others.

Aug 30, 2016

OTC Disclosure News Service

Newport Beach, CA




/* Style Definitions */
{mso-style-name:”Table Normal”;
mso-padding-alt:0in 5.4pt 0in 5.4pt;

CA–(Marketwired – August 29, 2016) – ADVANTIS CORPORATION (
OTC PINK:ADVT) addressed the promotional activities that took place on Friday, June
24th 2016. Emails campaigns were conducted by third parties that
were non compensated and unauthorized by Advantis to do so.


Advantis has
recently received information from a number of sources regarding an apparent
stock promotion program promoting its common stock, that has been initiated and
is being maintained by unrelated parties without the involvement, knowledge,
consent, or participation of the Company. Part of the promotion appears to be
based on a written “advertisement” being distributed to potential
market investors which contains multiple outrageous and unfounded claims and
assertions regarding Advantis. For the record, neither Advantis, or any
officer, director, individual owning more than 5% , employee or agent of
either, has authorized, paid for, or approved this advertisement, has never had
any contact or dealings of any kind, directly or indirectly, with Stellar Media
Group or anyone involved with the preparation or distribution of this
advertisement, and expressly repudiates the advertisement in its entirety.
Investors, shareholders and the investing public are cautioned about purchasing
stock in Advantis Group based on this advertisement or any related sales
efforts by unrelated third parties. The Company itself is not currently
offering or selling any common stock publicly and has not authorized or paid
for any person or entity to act on its behalf in connection with any sales or
promotional efforts related to its common stock. Any information regarding the
Company which is authorized and approved for public distribution will be issued
by the Company itself as a press release or public filing with the SEC or OTC Markets
Disclosure and News Service.


Advantis CEO, Christopher Swartz, stated: “It is unfortunate that both the
investing public and a small public company such as Advantis have become
targets of what appears to be a promotional stock scheme based on
misrepresentations and exaggerations about the Company. We have already completed
all the necessary updates and disclosures required by the OTC Markets to get
the Caveat Emptor removed, now it’s up to the OTC Markets to complete their review
for having the Caveat Emptor removed. We sincerely apologize to all of the
shareholders regarding this matter and have advised the OTC Markets that the
Company is not part of the promotion, did not authorize it, did not pay for it,
and did not approve any promotional materials. We have also confirmed that, to
the Company’s knowledge, no officer, director, individual owning more than 5%
or employee of the Company has offered or sold any of its or their shares during
this promotion. We have contacted our investor relations firm,, Inc. and confirmed that they too have not had any contact
with Stellar Media or any other group for email promotion of Advantis. From
what we have seen so far, every email sent stated that the companies were not
paid for and/or approved by Advantis.

Advantis Corporation
Advantis Corporation (ADVT) develops products and works with developing
companies to provide innovative healthcare products, holistic pain management
solutions, and enhance the footprint in the evolving legal cannabis business.
Advantis acquires ownership in developing companies that work within the
nutraceutical and the alternative health care industries; consulting with these
organizations to improve their product lines, expand their distribution
channels through internal partnership agreements, and heighten brand value.

Forward Looking Statements: This news release contains
forward-looking statements made by ADVANTIS CORPORATION. All such statements
included in this press release, other than statements of historical fact, are
forward-looking statements. Although management believes that the expectations
reflected in such forward-looking statements are reasonable, it can give no
assurance that such expectations will prove to have been correct. Actual
results may differ materially from those indicated by these statements. The
following risk factors, among others, could cause actual results to differ
materially from those described in any forward-looking statements. These risks
and uncertainties include, but are not limited to, economic conditions, changes
in the law or regulations, demand for products of the Company, the effects of
competition and other factors that could cause actual results to differ
materially from those projected or represented in the forward looking
statements. Forward-looking statements are typically identified by the words:
believe, expect, anticipate, intend, estimate, and similar expressions or which
by their nature refer to future events. The Company is not entitled to rely on
the safe harbor provisions of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934 because it is not registered
under either Act.


For further information,
Media Relations Contact
Name: Woo Kim, 
Director Phone: 949-354-3585



Stuart T. Smith



Address: 1 Corporate Plaza Drive #100 
Newport Beach Ca. 92660

Copyright © 2016 OTC Markets. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Leave a Reply